Branch retinal vein occlusion
Showing 1 - 25 of 8,023
Branch Retinal Vein Occlusion Trial in Damietta (aflibercept (2mg/0.05ml))
Completed
- Branch Retinal Vein Occlusion
- aflibercept (2mg/0.05ml)
-
Damietta, EgyptAkram Fekry Elgazzar
Nov 22, 2023
Branch Retinal Vein Occlusion, Ranibizumab, Laser Photocoagulation Trial in Beijing (Ranibizumab combined macular laser,
Completed
- Branch Retinal Vein Occlusion
- +2 more
- Ranibizumab combined macular laser
- Ranibizumab
-
Beijing, Beijing, ChinaBeijing Hospital
Dec 25, 2022
Functional Optical Coherence Tomography for Ocular Imaging
Completed
- Glaucoma
- +4 more
- Optical Coherence Tomography
-
Irvine, CaliforniaBeckman Laser Institute, University of California,Irvine
Oct 19, 2022
Branch Retinal Vein Occlusion, Macular Edema Trial in Odense, Roskilde (Aflibercept Injection [Eylea], Navigated laser
Completed
- Branch Retinal Vein Occlusion
- Macular Edema
- Aflibercept Injection [Eylea]
- Navigated laser photocoagulation
-
Odense, Danmark, Denmark
- +1 more
Apr 18, 2022
Retinal Vein Occlusion Trial in Bethesda, Bristol (Minocycline, Placebo, Bevacizumab)
Glaucoma, Glaucoma Suspect, Diabetic Retinopathy Trial in Philadelphia (Free Eye Screenings, Enhanced Intervention, Usual Care)
Completed
- Glaucoma
- +12 more
- Free Eye Screenings
- +2 more
-
Philadelphia, PennsylvaniaWills Eye Glaucoma Service
Aug 19, 2022
Branch Retinal Vein Occlusion, Retinal Blood Flow, Retinal Oxygen Saturation Trial in Vienna (Dynamic Vessel Analyzer,
Recruiting
- Branch Retinal Vein Occlusion
- +2 more
- Dynamic Vessel Analyzer
- Bidirectional Fourier-Domain Optical Coherence Tomography (FDOCT)
-
Vienna, AustriaDepartment of Clinical Pharmacology, Medical University of Vienn
Apr 6, 2022
Use of Aflibercept Injections Into Eye for Treatment of Eye
Recruiting
- Retinal Disease
- Aflibercept (BAY86-5321, Eylea)
-
Multiple Locations, MexicoMany locations
Aug 22, 2022
Central Retinal Vein Occlusion With Macular Edema, Branch Retinal Vein Occlusion With Macular Edema Trial in Taiwan (TLC399)
Completed
- Central Retinal Vein Occlusion With Macular Edema
- Branch Retinal Vein Occlusion With Macular Edema
-
Chang Hua, Taiwan
- +5 more
Nov 24, 2021
Age-Related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in Springfield,
Active, not recruiting
- Age-Related Macular Degeneration
- +4 more
- bevacizumab
-
Springfield, Illinois
- +2 more
Dec 6, 2021
Retinal Vein Occlusion, Diabetic Macular Edema, Branch Retinal Vein Occlusion Trial in Cleveland (Aflibercept)
Completed
- Retinal Vein Occlusion
- +3 more
-
Cleveland, OhioCole Eye Institute, Cleveland Clinic
May 10, 2021
Branch Retinal Vein Occlusion With Macular Edema Trial in Stockholm (Aflibercept Injection [Eylea], Ranibizumab Injection
Recruiting
- Branch Retinal Vein Occlusion With Macular Edema
- Aflibercept Injection [Eylea]
- Ranibizumab Injection [Lucentis]
-
Stockholm, SwedenSt Eriks Eye Hospital
Dec 2, 2020
Branch Retinal Vein Occlusion Trial in BeiJing (601 1.25mg, Ranibizuman 0.5 mg)
Not yet recruiting
- Branch Retinal Vein Occlusion
- 601 1.25mg
- Ranibizuman 0.5 mg
-
BeiJing, Beijing, ChinaBeiJing Hospital
Dec 8, 2020
Branch Retinal Vein Occlusion Trial in Worldwide (Brolucizumab 6 mg, Aflibercept 2 mg, Sham injection)
Terminated
- Branch Retinal Vein Occlusion
- Brolucizumab 6 mg
- +2 more
-
Phoenix, Arizona
- +101 more
Jan 27, 2023
Branch Retinal Vein Occlusion Trial in Shenyang (Bevacizumab Ophthalmic and Intravitreal Dexamethasone, Bevacizumab Ophthalmic)
Unknown status
- Branch Retinal Vein Occlusion
- Bevacizumab Ophthalmic and Intravitreal Dexamethasone
- Bevacizumab Ophthalmic
-
Shenyang, Liaoning, ChinaHe Eye Specialist Hospital
Oct 20, 2020
Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in United States
Completed
- Age-related Macular Degeneration
- +4 more
- bevacizumab
-
Tucson, Arizona
- +19 more
Nov 16, 2021
Retinal Vein Occlusion Trial in France
Active, not recruiting
- Retinal Vein Occlusion
-
Créteil, France
- +8 more
Aug 17, 2022
Macular Edema, Branch Retinal Vein Occlusion Trial in Worldwide (Faricimab, Aflibercept, Sham Procedure)
Active, not recruiting
- Macular Edema
- Branch Retinal Vein Occlusion
- Faricimab
- +2 more
-
Phoenix, Arizona
- +151 more
Aug 4, 2022
Central Retinal Vein Occlusion With Macular Edema Trial in Peshawar (Group A)
Completed
- Central Retinal Vein Occlusion With Macular Edema
- Group A
-
Peshawar, KPK, PakistanHayatabad Medical Complex
Apr 3, 2022
Retinal Vein Occlusion, Obstructive Sleep Apnea Trial in Orléans (Sleeping Monitor)
Withdrawn
- Retinal Vein Occlusion
- Obstructive Sleep Apnea
- Sleeping Monitor
-
Orléans, FranceCHR d'Orléans
Oct 20, 2021
Retinal Vein Occlusion Trial in Winston-Salem (Aflibercept Ophthalmic)
Recruiting
- Retinal Vein Occlusion
- Aflibercept Ophthalmic
-
Winston-Salem, North CarolinaWake Forest Health Sciences
Jan 5, 2022
Artificial Intelligence Diagnostic Aid
Not yet recruiting
- Wet Macular Degeneration
- +2 more
- Macusense Assessment Software
-
London, Westminster, United KingdomGuy's and St Thomas's NHS Foundation Trust
Dec 29, 2022
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion Trial in Shanghai (BD311)
Recruiting
- Neovascular Age-related Macular Degeneration
- +2 more
- BD311
-
Shanghai, Shanghai, ChinaEye & ENT Hospital of Fudan University
Aug 22, 2022
Retinal Vein Occlusion Trial in Damietta (Triamcinolone Acetonide)
Completed
- Retinal Vein Occlusion
- Triamcinolone Acetonide
-
Damietta, EgyptAkram Fekry Elgazzar
Apr 21, 2022